METABRAIN RES has a total of 32 patent applications. It decreased the IP activity by 85.0%. Its first patent ever was published in 2012. It filed its patents most often in France, Canada and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are ARISGEN SA, G1 THERAPEUTICS INC and SEED RES INSTITUTE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | France | 5 | |
#2 | Canada | 4 | |
#3 | China | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | United States | 4 | |
#6 | WIPO (World Intellectual Property Organization) | 4 | |
#7 | Australia | 3 | |
#8 | Republic of Korea | 3 | |
#9 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Sugars | |
#5 | Unspecified technologies | |
#6 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Raynal Sophie N | 27 |
#2 | Autier Valerie | 23 |
#3 | Kergoat Micheline R | 20 |
#4 | Audet Annick M | 20 |
#5 | Lepifre Franck F | 20 |
#6 | Charon Christine G | 20 |
#7 | Durand Jean-Denis | 14 |
#8 | Lena Gersande R | 13 |
#9 | Audet Annick | 11 |
#10 | Charon Christine | 11 |
Publication | Filing date | Title |
---|---|---|
FR3069434A1 | Anthranilic acid in the treatment of muscle atrophy | |
FR3055548A1 | USE OF METABOLITES OF TRYPTOPHAN IN THE TREATMENT OF MUSCLE ATROPHY | |
FR3035105A1 | Derivatives useful in the treatment of muscle atrophy | |
FR2993564A1 | IMIDAZOPYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF DIABETES | |
FR2993563A1 | THIOPHENE DERIVATIVES USEFUL IN THE TREATMENT OF DIABETES |